PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.63%
Negative revenue growth while QCOM stands at 5.46%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-0.43%
Negative gross profit growth while QCOM is at 9.94%. Joel Greenblatt would examine cost competitiveness or demand decline.
-2.53%
Negative EBIT growth while QCOM is at 46.93%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-0.40%
Negative operating income growth while QCOM is at 46.93%. Joel Greenblatt would press for urgent turnaround measures.
9.72%
Net income growth under 50% of QCOM's 82.81%. Michael Burry would suspect the firm is falling well behind a key competitor.
10.53%
EPS growth under 50% of QCOM's 92.86%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
10.71%
Diluted EPS growth under 50% of QCOM's 90.48%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.21%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.53%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.21%
Dividend growth under 50% of QCOM's 4.49%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
-51.48%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-56.63%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
37.56%
10Y revenue/share CAGR under 50% of QCOM's 177.91%. Michael Burry would suspect a lasting competitive disadvantage.
18.56%
5Y revenue/share CAGR above 1.5x QCOM's 3.84%. David Dodd would look for consistent product or market expansions fueling outperformance.
4.90%
3Y revenue/share CAGR at 50-75% of QCOM's 9.34%. Martin Whitman would question if the firm lags behind competitor innovations.
58.74%
10Y OCF/share CAGR above 1.5x QCOM's 31.88%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
56.76%
Positive OCF/share growth while QCOM is negative. John Neff might see a comparative advantage in operational cash viability.
14.75%
3Y OCF/share CAGR above 1.5x QCOM's 4.74%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
136.30%
Net income/share CAGR above 1.5x QCOM's 60.75% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
100.76%
Positive 5Y CAGR while QCOM is negative. John Neff might view this as a strong mid-term relative advantage.
26.23%
Below 50% of QCOM's 75.23%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
4.46%
Positive growth while QCOM is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
-16.33%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-22.07%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
647.52%
10Y dividend/share CAGR above 1.5x QCOM's 265.38%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
165.01%
5Y dividend/share CAGR above 1.5x QCOM's 47.90%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
80.30%
3Y dividend/share CAGR above 1.5x QCOM's 17.00%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
22.53%
AR growth well above QCOM's 10.76%. Michael Burry fears inflated revenue or higher default risk in the near future.
0.10%
Inventory shrinking or stable vs. QCOM's 1.43%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-4.08%
Negative asset growth while QCOM invests at 0.47%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-12.98%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
6.76%
Debt growth far above QCOM's 0.01%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-2.33%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
1.21%
We expand SG&A while QCOM cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.